Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA
Target Price
The average target price of INFU is 13 and suggests 78% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell